200 related articles for article (PubMed ID: 26888607)
1. TRPV-1-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues.
Matsuura K; Seta H; Haraguchi Y; Alsayegh K; Sekine H; Shimizu T; Hagiwara N; Yamazaki K; Okano T
Sci Rep; 2016 Feb; 6():21747. PubMed ID: 26888607
[TBL] [Abstract][Full Text] [Related]
2. Induced Pluripotent Stem Cell Elimination in a Cell Sheet by Methionine-Free and 42°C Condition for Tumor Prevention.
Matsuura K; Ito K; Shiraki N; Kume S; Hagiwara N; Shimizu T
Tissue Eng Part C Methods; 2018 Oct; 24(10):605-615. PubMed ID: 30234460
[TBL] [Abstract][Full Text] [Related]
3. Elimination of remaining undifferentiated induced pluripotent stem cells in the process of human cardiac cell sheet fabrication using a methionine-free culture condition.
Matsuura K; Kodama F; Sugiyama K; Shimizu T; Hagiwara N; Okano T
Tissue Eng Part C Methods; 2015 Mar; 21(3):330-8. PubMed ID: 25245976
[TBL] [Abstract][Full Text] [Related]
4. Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering.
Haraguchi Y; Matsuura K; Shimizu T; Yamato M; Okano T
J Tissue Eng Regen Med; 2015 Dec; 9(12):1363-75. PubMed ID: 23728860
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.
Brodarac A; Šarić T; Oberwallner B; Mahmoodzadeh S; Neef K; Albrecht J; Burkert K; Oliverio M; Nguemo F; Choi YH; Neiss WF; Morano I; Hescheler J; Stamm C
Stem Cell Res Ther; 2015 Apr; 6(1):83. PubMed ID: 25900017
[TBL] [Abstract][Full Text] [Related]
6. Human gingival fibroblast feeder cells promote maturation of induced pluripotent stem cells into cardiomyocytes.
Matsuda Y; Takahashi K; Kamioka H; Naruse K
Biochem Biophys Res Commun; 2018 Sep; 503(3):1798-1804. PubMed ID: 30060947
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.
Kawamura M; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura T; Kuratani T; Daimon T; Shimizu T; Okano T; Sawa Y
Circulation; 2012 Sep; 126(11 Suppl 1):S29-37. PubMed ID: 22965990
[TBL] [Abstract][Full Text] [Related]
8. Dinaciclib potently suppresses MCL-1 and selectively induces the cell death in human iPS cells without affecting the viability of cardiac tissue.
Alsayegh K; Matsuura K; Sekine H; Shimizu T
Sci Rep; 2017 Mar; 7():45577. PubMed ID: 28361959
[TBL] [Abstract][Full Text] [Related]
9. Contractile Force Measurement of Engineered Cardiac Tissues Derived from Human iPS Cells.
Sasaki D; Matsuura K; Shimizu T
Methods Mol Biol; 2021; 2320():161-170. PubMed ID: 34302657
[TBL] [Abstract][Full Text] [Related]
10. Protocol for Morphological and Functional Phenotype Analysis of hiPS-Derived Cardiomyocytes.
Li J; Lee JK
Methods Mol Biol; 2021; 2320():91-100. PubMed ID: 34302651
[TBL] [Abstract][Full Text] [Related]
11. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes.
Jiang B; Dong H; Li Q; Yu Y; Zhang Z; Zhang Y; Wang G; Zhang Z
Cell Biochem Biophys; 2013 Jun; 66(2):309-18. PubMed ID: 23212180
[TBL] [Abstract][Full Text] [Related]
13. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
14. Tubular Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells Generate Pulse Pressure In Vivo.
Seta H; Matsuura K; Sekine H; Yamazaki K; Shimizu T
Sci Rep; 2017 Mar; 7():45499. PubMed ID: 28358136
[TBL] [Abstract][Full Text] [Related]
15. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.
Lim SY; Sivakumaran P; Crombie DE; Dusting GJ; Pébay A; Dilley RJ
Methods Mol Biol; 2016; 1357():415-21. PubMed ID: 25520285
[TBL] [Abstract][Full Text] [Related]
17. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
[TBL] [Abstract][Full Text] [Related]
18. Generation of Cylindrical Engineered Cardiac Tissues from Human iPS Cell-Derived Cardiovascular Cell Lineages.
Masumoto H
Methods Mol Biol; 2021; 2320():81-88. PubMed ID: 34302650
[TBL] [Abstract][Full Text] [Related]
19. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
[TBL] [Abstract][Full Text] [Related]
20. Creation of human cardiac cell sheets using pluripotent stem cells.
Matsuura K; Wada M; Shimizu T; Haraguchi Y; Sato F; Sugiyama K; Konishi K; Shiba Y; Ichikawa H; Tachibana A; Ikeda U; Yamato M; Hagiwara N; Okano T
Biochem Biophys Res Commun; 2012 Aug; 425(2):321-7. PubMed ID: 22842572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
